4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.

      Cancer research

      Animals, Apoptosis, physiology, Basic Helix-Loop-Helix Transcription Factors, biosynthesis, genetics, Cell Survival, Homeodomain Proteins, Humans, Liver Neoplasms, secondary, Lung Neoplasms, Mammary Neoplasms, Experimental, metabolism, pathology, Mice, Protein Kinase Inhibitors, pharmacology, Protein-Serine-Threonine Kinases, antagonists & inhibitors, Proto-Oncogene Proteins c-akt, RNA, Messenger, Receptors, Platelet-Derived Growth Factor, Receptors, Transforming Growth Factor beta, Signal Transduction, Smad Proteins, Transforming Growth Factor beta, Tumor Suppressor Proteins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Transforming growth factor-beta (TGF-beta) signaling facilitates tumor growth and metastasis in advanced cancer. In the present study, we identified differentially expressed in chondrocytes 1 (DEC1, also known as SHARP2 and Stra13) as a downstream target of TGF-beta signaling, which promotes the survival of breast cancer cells. In the mouse mammary carcinoma cell lines JygMC(A) and 4T1, the TGF-beta type I receptor kinase inhibitors A-44-03 and SB431542 induced apoptosis of cells under serum-free conditions. Oligonucleotide microarray and real-time reverse transcription-PCR analyses revealed that TGF-beta induced DEC1 in these cells, and the increase of DEC1 was suppressed by the TGF-beta type I receptor kinase inhibitors as well as by expression of dominant-negative TGF-beta type II receptor. Overexpression of DEC1 prevented the apoptosis of JygMC(A) cells induced by A-44-03, and knockdown of endogenous DEC1 abrogated TGF-beta-promoted cell survival. Moreover, a dominant-negative mutant of DEC1 prevented lung and liver metastasis of JygMC(A) cells in vivo. Our observations thus provide new insights into the molecular mechanisms governing TGF-beta-mediated cell survival and metastasis of cancer.

          Related collections

          Author and article information

          Journal
          17942899
          10.1158/0008-5472.CAN-07-1522

          Comments

          Comment on this article